Bristol-Myers Squibb Co. (BMY)

Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
Quarterly Data

Difficulty: Beginner

Annual Data

Quarterly Data

Bristol-Myers Squibb Co., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity

	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014	Dec 31, 2013	Sep 30, 2013	Jun 30, 2013	Mar 31, 2013
Short-term debt obligations
Accounts payable
Accrued liabilities
Deferred income
Income taxes payable
Liabilities related to assets held-for-sale
Current liabilities	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%
Deferred income
Income taxes payable
Deferred income taxes
Pension and other liabilities
Long-term debt, excluding current portion
Noncurrent liabilities	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%
Total liabilities	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%
Preferred stock
Common stock
Capital in excess of par value of stock
Accumulated other comprehensive loss
Retained earnings
Cost of treasury stock
Total Bristol-Myers Squibb Company shareholders' equity	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%
Noncontrolling interest
Total equity	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%
Total liabilities and equity	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%	%

	Bristol-Myers Squibb Co.	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality